<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        34-93-18
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2018
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        BELKYRA 10MG/ML SOLUTION FOR INJECTION
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DEOXYCHOLIC ACID
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Subcutaneous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        3603.6
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Hospira, Inc. " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Hospira, Inc. 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Allergan Inc
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        D11AX24
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Belkyra contains the active substance deoxycholic acid. Deoxycholic acid is produced naturally in your body to aid in the digestion of fats.</p><p>BELKYRA is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called &ldquo;double chin.&rdquo;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not use belkyra:</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are hypersensitive (allergic) to deoxycholic acid or any of the other ingredients of BELKYRA.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have an infection at the treatment area.</p><p><em>&nbsp;</em></p><p><strong>Warnings and precautions:</strong></p><p>Tell your doctor or healthcare professional before being given the injection:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have had or plan to have surgery on your face, neck, or chin.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have had cosmetic treatments on your face, neck, or chin.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have had or have medical conditions in or near the neck area.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have had or have trouble swallowing.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have bleeding problems.</p><p><strong>&nbsp;</strong></p><p><strong>Children and adolescents</strong></p><p>&nbsp;It is not known if BELKYRA is safe and effective in children less than 18 years of age.</p><p>&nbsp;</p><p><strong>Elderly patients:</strong></p><p>Clinical trials included limited number of subjects aged 65 and over and has not identified clinically relevant differences in responses between the elderly and younger patients. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.</p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and BELKYRA:</strong></p><p><strong>Tell your healthcare provider about all the medicines you take</strong>, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take a medicine that prevents the clotting of your blood (antiplatelet or anticoagulant medicine).</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding:</strong></p><p>It is not known if BELKYRA will harm your unborn baby.</p><p>It is not known if BELKYRA passes into your breast milk. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine.</p><p>&nbsp;</p><p><strong>Driving and using machines:</strong></p><p>No studies on the effects on the ability to drive and use machines have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>BELKYRA is injected into the fat under your chin (up to 50 injections under your skin) by your healthcare provider. Your doctor or nurse will determine the dose you will receive and supervise the injection.</p><p>The total number of injections and treatment sessions needed to achieve a satisfactory response depends upon your individual needs. Treatment can be repeated multiple times but should not exceed 6 treatment sessions; 2 to 4 treatment sessions are usually sufficient. You and your healthcare provider will decide how many treatments you need. BELKYRA injections will be given at least 1 month apart.</p><p><strong>&nbsp;</strong></p><p><strong>If you use more BELKYRA </strong></p><p>Injection of increased volume or decreasing the spacing of BELKYRA may increase the risk of adverse reactions.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p><p>&nbsp;</p><p>Belkyra can cause serious side effects, including:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Nerve injury in the jaw that can cause an uneven smile or facial muscle weakness.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trouble swallowing.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Injection site problems including:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; bruising</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; hair loss</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; open sores (ulcers)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; damage and tissue cell-death (necrosis) around the injection site</p><p>&nbsp;</p><p><strong>Very common side effects </strong></p><p>These may affect one or more users in 10</p><p><u>Injection site reactions:</u></p><ul><li>Swelling.</li><li>Bruising.</li><li>Pain.</li><li>Numbness.</li><li>Redness.</li><li>Areas of hardness in the treatment area.</li><li>Tingling sensation.</li><li>Small round area of localized hardness&nbsp; (Nodule)</li><li>Itching.</li></ul><p><u>&nbsp;</u></p><p><strong>Common side effects</strong></p><p>These may affect one or more users in 100:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nausea.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Difficulties in swallowing (dysphagia).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin tightness at site of injection.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Warmth at the site of injection.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nerve injury at site of injection</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Sore throat.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; High blood pressure.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bleeding at the site of injection</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Discolouration at the site of injection</p><p>&nbsp;</p><p><strong>Uncommon frequency side effects: &nbsp;</strong></p><p>These may affect one or more use in 1000:</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hives at injection site</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swollen lymph nodes at site of injection</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Neck Pain</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fainting</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lightheadedness</p><p>&nbsp;</p><p><strong>Unknown frequency:</strong></p><p>Frequency cannot be estimated from the available data</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Open sores (ulcers).</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Damage and tissue cell-death (necrosis) around the injection site.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hair loss in men.</p><p>&nbsp;</p><p>Advise patients to contact their healthcare providers if patients begin to develop signs of marginal mandibular nerve paresis (e.g., asymmetric smile, facial muscle weakness), difficulty swallowing, or worsening of existing symptoms.&nbsp;</p><p>Advise patients to contact their healthcare providers for development of open sore(s) or drainage from the treatment area.</p><p>&nbsp;</p><p><u>Reporting side effects</u></p><p>If any of the side effects get serious, or if you notice any side effects not mentioned in this leaflet, please tell your doctor or pharmacist. You can also report side effects directly via national reporting system listed in 6.&nbsp; By reporting side effects you can help provide more information on the safety of the medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the vial label and the carton after EXP:. The expiry date refers to the last day of that month.</p><p>Store below 30&deg;C.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is<strong> deoxycholic acid </strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are benzyl alcohol, dibasic sodium phosphate, hydrochloric acid, sodium chloride, sodium hydroxide and water for injection, USP.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                BELKYRA injection is a clear, colorless, sterile solution supplied in 2 mL vials.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer</strong></p><p>Hospira, Inc.</p><p>1776 North Centennial, McPherson</p><p>United states</p><p>&nbsp;</p><p><strong>Marketing Authorisation Holder and </strong></p><p>Allergan Inc.</p><p>2525 Dupont Drive</p><p>Irvine</p><p>United States</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was revised in January 2018.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي بيلكايرا على حمض ديوكسي كوليك كمادة فعالة. يُنتج حمض الديوكسي كوليك بصورة طبيعية داخل الجسم للمساعدة في عملية هضم الدهون</p><p>&nbsp;</p><p>بيلكايرا هو دواء يؤخذ حسب وصف الطبيب ويُستخدم من قبل البالغين لتحسين المظهر والمظهر الجانبي للدهون المعتدلة إلى الحادة المتراكمة أسفل الذقن، وتُعرف أيضاً باسم &quot;الذقن المزدوج&quot;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>:يرجى عدم استخدام بيلكايرا في الحالات التالية</p><p>&nbsp; إذا كنت تعاني حساسية مفرطة لحمض الديوكسي كوليك أو أي من المكونات الأخرى لدواء بيلكايرا-</p><p>&nbsp;إذا كنت مصاباً بعدوى في المنطقة المستهدف علاجها-</p><p>&nbsp;</p><p><strong>الاحتياطات والتحذيرات:</strong></p><p>&nbsp;</p><p>:أخبر طبيبك أو أخصائي الرعاية الصحية قبل خضوعك للحقن</p><p>&nbsp; إذا كنت قد خضعت مسبقاً أو تخطط لخضوع لجراحة في وجهك أو رقبتك أو ذقنك-</p><p>&nbsp; إذا كنت قد خضعت لعلاجات تجميلية في وجهك أو رقبتك أو ذقنك-</p><p>&nbsp;إذا كنت قد أصبت أو مصاباً بالفعل بحالات مَرَضية في أو بالقرب من منطقة الرقبة-</p><p>&nbsp; إذا كنت قد أصبت أو مصاباً بالفعل بمشكلة في البلع-</p><p>&nbsp; إذا كنت تعاني مشكلات نزفية-</p><p>&nbsp;</p><p><strong>:الأطفال والمراهقون</strong></p><p>&nbsp;من غير المعروف إذا ما كان بيلكايرا آمناً وفعالاً للأطفال الذين تقل أعمارهم عن 18 سنة أم لا</p><p><strong>&nbsp;</strong></p><p><strong>:المرضى الكبار في السن</strong></p><p>شملت التجارب السريرية عددًا محدودًا من الأشخاص الذين تبلغ أعمارهم 65 عامًا أو أكثر ولم تحدد اختلاف في الاستجابة بين المرضى المسنين والأصغر سناً. لم تحدد التجارب السريرية الأخرى التي تم الإبلاغ عنها اختلاف في الاستجاب بين كبار السن والمرضى الأصغر سنا</p><p><strong>&nbsp;</strong></p><p><strong>:الأدوية الأخرى وبيلكايرا</strong></p><p><strong>أخبر مزود الرعاية الصحية عن جميع الأدوية التي تتناولها</strong>، بما في ذلك الأدوية التي تؤخذ حسب أو دون وصف الطبيب والفيتامينات والمكملات العشبية. وكذلك أخبر مزود الرعاية&nbsp; . الصحية إذا كنت تتناول دواءً يقي من تجلط الدم (دواءً مضاداً لتراكم الصفائح الدموية أو دواءً مانعاً للتجلط</p><p>&nbsp;</p><p><strong>:الحمل والرضاعة</strong></p><p>من غير المعروف ما إذا كان لبيلكايرا آثار ضارة على الجنين أم لا</p><p>من غير المعروف ما إذا كان بيلكايرا يُفرز في حليب الأم أم لا. إذا كنتِ حاملاً أو مرضعاً أو تعتقدين بأنكِ حامل أو أنكِ تعتزمين الحمل، فاطلبي النصيحة من الطبيب أو الممرضة قبل تناول هذا الدواء</p><p>&nbsp;</p><p><strong>:القيادة وتشغيل الآلات</strong></p><p>لم تُجرَ أي دراسات حول أثر الدواء في القدرة على القيادة واستعمال الآلات</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يُحقن بيلكايرا في الدهون الموجودة أسفل الذقن (حتى 50 حقنة تحت الجلد) من قبل مزود الرعاية الصحية. سيقوم طبيبك أو الممرضة بتحديد الجرعة التي ستتلقاها وبالإشراف على عملية الحقن</p><p>يعتمد العدد الكلي لعمليات الحقن والجلسات العلاجية اللازمة لتحقيق استجابة مُرضية على احتياجات كل فرد. يمكن تكرار العلاج للعديد من المرات ولكن يجب ألا يتجاوز 6 جلسات علاجية؛ عادة ما يكفي 2 إلى 4 جلسات علاجية.&nbsp; ستقرر أنت ومزود الرعاية الصحية عدد العلاجات التي تحتاج إليها. بحيث يفصل بين اعطاء حقن بيلكايرا شهر واحد على الأقل</p><p>&nbsp;</p><p><strong>:في حال استخدام جرعة زائدة من بيلكايرا</strong></p><p>قد يؤدي الحقن بجرعة زائدة من بيلكايرا أو قلة المدة الفاصلة بين كل عملية حقن وأخرى إلى زيادة خطر الإصابة بتفاعلات عكسية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن كل الأدوية، قد يسبب هذا الدواء آثاراً جانبية، ولكنها لا تظهر بالضرورة على كل من يتناوله</p><p>إذا شعرت بأي أعراض جانبية فتحدث إلى طبيبك أو الصيدلي. ويشمل ذلك أي آثار جانبية محتملة غير مدرجة في هذه النشرة</p><p>&nbsp;</p><p>:يمكن أن يسبب بيلكايرا آثاراً جانبية خطيرة ومنها</p><p>&nbsp; ضرر عصبي بالفك يمكن أن يؤدي إلى ابتسامة غير مستوية أو ضعف في عضلات الوجه</p><p>&nbsp; صعوبة في البلع</p><p><u>:مشاكل في مكان الحقن تشمل</u></p><p>كدمات</p><p>تساقط الشعر</p><p>&nbsp; (قروح مفتوحة (قرحة</p><p>تلف الأنسجة وموت الخلايا (نخر) حول موقع الحقن</p><p>&nbsp;</p><p><strong>:الآثار الجانبية الشائعة جدا</strong></p><p>:قد تؤثر في شخص واحد أو أكثر من كل 10 أشخاص</p><p><u>:تفاعلات بمكان الحقن</u></p><p>تورم</p><p>كدمات</p><p>ألم</p><p>شعور بالخدر</p><p>احمرار</p><p>مناطق متصلبة في منطقة العلاج</p><p>&nbsp; &nbsp;شعور بالوخز</p><p>&nbsp; (&nbsp;منطقة مستديرة صغيرة من الخلايا المتصلبة المتمركزة&nbsp; (عقدة</p><p>حكة</p><p>&nbsp;</p><p><strong>:الآثار الجانبية الشائعة</strong></p><p>:قد تؤثر في شخص واحد أو أكثر من كل 100 شخص</p><p>غثيان</p><p>صعوبة في البلع</p><p>شد في الجلد في مكان الحقن</p><p>سخونة في مكان الحقن</p><p>اصابة في العصب في مكان الحقن</p><p>صداع</p><p>التهاب في الحلق</p><p>ارتفاع ضغط الدم</p><p>&bull;نزيف في مكان الحقن</p><p>تغير اللون في مكان الحقن</p><p><strong>&nbsp;</strong></p><p><strong>:الآثار الجانبية غير الشائعة</strong></p><p>:قد تؤثر في شخص واحد أو أكثر من كل 1000 شخص</p><p>طفح جلدي (شرى) في موقع الحقن</p><p>تضخم الغدد الليمفاوية في موقع الحقن</p><p>الم في الرقبة</p><p>دوخة</p><p>إغماء</p><p>&nbsp;دوار</p><p>&nbsp;</p><p><strong>الآثار الجانبية غير معروفة التكرار</strong></p><p>لا يمكن تقدير تكرارها من البيانات المتاحة</p><p>(قروح مفتوحة (قرحة</p><p>موت و تلف الأنسجة (نخر) حول موقع الحقن</p><p>تساقط الشعر عند الرجال</p><p>&nbsp;</p><p>يُنصح المرضى بالاتصال بمقدمي الرعاية الصحية الخاصة بهم إذا بدأ ظهور علامات شلل العصب الفك السفلي الهامشي (على سبيل المثال ، الابتسامة غير المتماثلة ، ضعف عضلات الوجه) ، صعوبة في البلع ، أو تفاقم الأعراض الموجودة</p><p>يُنصح المرضى للاتصال بمقدمي الرعاية الصحية الخاصة بهم اذا بدأ ظهور القروح المفتوحة أو السوائل من منطقة العلاج</p><p>&nbsp;</p><p><strong><u>:الإبلاغ عن الإصابة بالآثار الجانبية</u></strong>&nbsp;&nbsp;</p><p>إذا تطور أي من هذه الآثار الجانبية لدرجة خطيرة، أو إذا لاحظت حدوث أي آثار&nbsp; جانبية غير واردة بهذه النشرة، أخبر الطبيب أو الصيدلي. يمكنك أيضاً الإبلاغ عن الآثار الجانبية مباشرة من خلال نظام الإبلاغ الوطني المذكور في القسم 6. إن الإبلاغ عن الآثار الجانبية من شأنه المساعدة من خلال توفير المزيد من المعلومات حول سلامة هذا المنتج</p><p>&nbsp;</p><p>&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ هذا الدواء بعيداً عن متناول الأطفال ومرأى نظرهم</p><p>EXPلا يستعمل هذا الدواء بعد انتهاء تاريخ الصلاحية الموضح على البطاقة الملصقة على القنينة والعلبة بعد كلمة&nbsp;</p><p>ويشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر</p><p>يُحفظ في درجة حرارة أقل من 30 درجة مئوية</p><p>لا ينبغي التخلص من أي أدوية عن طريق مياه الصرف أو النفايات المنزلية. اسأل الصيدلي عن طريقة التخلص من الأدوية التي لم تعد تستعملها. تساعد هذه التدابير في حماية البيئة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي حمض الديوكسي كوليك</p><p>&nbsp;المكونات الأخرى هي كحول بنزيلي، فوسفات صوديوم ثنائي القاعدة، حمض هيدروكلوريك، كلوريد صوديوم، هيدروكسيد صوديوم، ماء للحقن، دستور الأدوية الأمريكي</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            بيلكايرا حقن هو محلول معقم رائق عديم اللون يتوفر في قنينات بحجم 2 مل.
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>الشركة المُصنعة</strong></p><p>هوسبيرا انك</p><p>1776 نورث سنتينيال، مكفيرسون</p><p>الولايات المتحدة الأمريكية</p><p><strong>&nbsp;</strong></p><p><strong>الشركة</strong><strong> المالكة لحق التسويق </strong></p><p>شركة أليرجان</p><p>2525 طريق دوبونت</p><p>إرفاين</p><p>الولايات المتحدة الأمريكية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة في يناير 2018.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                BELKYRA (deoxycholic acid) 10mg/ml injection.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The active ingredient is deoxycholic acid 10 mg/ml.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                BELKYRA injection is a clear, colorless, sterile solution supplied in 2 mL vials.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.</p><p>Limitation of use: The safe and effective use of BELKYRA for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology</u></p><p>BELKYRA is injected into subcutaneous fat tissue in the submental area using an area-adjusted dose of 2 mg/cm<sup>2</sup>.</p><ul><li>A single treatment consists of up to a maximum of 50 injections, 0.2 mL each (up to a total of 10 mL), spaced 1 cm apart.</li></ul><p>Up to 6 single treatments may be administered at intervals no less than 1 month apart.</p><p><em>Paediatric population</em>:</p><p>Safety and effectiveness in patients below the age of 18 years have not been established and BELKYRA is not intended for use in children or adolescents.</p><p><em>&nbsp;</em></p><p><em>Elderly patients:</em></p><p>&nbsp;</p><p>Clinical trials included limited number of subjects aged 65 and over and has not identified clinically relevant differences in responses between the elderly and younger patients. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.</p><p>&nbsp;In general, treatment for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p><p>&nbsp;</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>BELKYRA should be administered by a healthcare professional.&nbsp;</p><p>Screen patients for other potential causes of submental convexity/fullness (e.g., thyromegaly and cervical lymphadenopathy).</p><p>Give careful consideration to the use of BELKYRA in patients with excessive skin laxity, prominent platysmal bands or other conditions for which reduction of submental fat may result in an aesthetically undesirable outcome.</p><p>Use caution in patients who have had prior surgical or aesthetic treatment of the submental area. Changes in anatomy/landmarks or the presence of scar tissue may impact the ability to safely administer BELKYRA or to obtain the desired aesthetic result.&nbsp;</p><p>BELKYRA is clear, colorless and free of particulate matter.&nbsp; Visually inspect BELKYRA vials for particulate matter and/or discoloration, and discard the vial if the solution is discolored and/or contains particulate matter. &nbsp;</p><p>After use, discard any remaining solution in the vial.</p><p>&nbsp;</p><p><strong>Injection Technique</strong></p><p>The safe and effective use of BELKYRA depends on the use of the correct number and locations for injections, proper needle placement, and administration techniques.</p><p>Health care professionals administering BELKYRA must understand the relevant submental anatomy and associated neuromuscular structures in the area involved and any alterations to the anatomy due to prior surgical or aesthetic procedures <em>[see Warnings and Precautions for use 4.4].</em></p><p>&nbsp;</p><p><strong><u>Avoid injections near the area of the marginal mandibular nerve <em>[see Warnings and Precautions for use 4.4 ]</em></u></strong></p><p>Needle placement with respect to the mandible is very important as it reduces the potential for injury to the marginal mandibular nerve, a motor branch of the facial nerve.&nbsp; Injury to the nerve presents as an asymmetrical smile due to paresis of lip depressor muscles <em>[see Warnings and Precautions for use (4.4)]</em>.</p><p>To avoid injury to the marginal mandibular nerve:</p><ul><li>Do not inject above the inferior border of the mandible.</li><li>Do not inject within a region defined by a 1-1.5 cm line below the inferior border (from the angle of the mandible to the mentum).</li><li>Inject BELKYRA only within the target submental fat treatment area (see Figures 1 and 3).</li></ul><p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Figure 1.&nbsp; Avoid the Marginal Mandibular Nerve Area </strong></p><p><img alt="" width="680" height="284" src="data:image/png;base64,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" /></p><p><strong><u>Avoid injection into the platysma </u></strong></p><p>Prior to each treatment session, palpate the submental area<strong> to ensure sufficient submental fat </strong>and to identify subcutaneous fat between the dermis and platysma (pre-platysmal fat) within the target treatment area (Figure 2).&nbsp; The number of injections and the number of treatments should be tailored to the individual patient&rsquo;s submental fat distribution and treatment goals.</p><p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Figure 2. Sagittal View of Platysma Area</strong></p><p><img alt="" width="550" height="230" src="data:image/png;base64,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" /></p><p><strong><u>Injecting into the treatment area</u></strong></p><p>Use of ice/cold packs, topical and/or injectable local anesthesia (e.g., lidocaine) may enhance patient comfort.</p><p>Outline the planned treatment area with a surgical pen and apply a 1 cm injection grid to mark the injection sites (Figures 2 and 3).</p><p><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Figure 3. Treatment Area and Injection Pattern</strong></p><p><img alt="" width="580" height="242" src="data:image/png;base64,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" /></p><p><strong>Do not inject BELKYRA outside the defined parameters <em>[see Warnings and Precautions 4.4]</em>.</strong></p><ul><li>Using a large bore needle, draw 1&nbsp;mL of BELKYRA into a sterile 1 mL syringe and expel any air bubbles in the syringe barrel.&nbsp;</li><li>Have the patient tense the platysma. Pinch the submental fat and, using a 30 gauge (or smaller) 0.5 inch needle, inject 0.2 mL of BELKYRA into the pre-platysmal fat (see Figure 2) next to each of the marked injection sites by advancing the needle perpendicular to the skin.</li><li>Injections that are too superficial (into the dermis) may result in skin ulceration and necrosis. Do not withdraw the needle from the subcutaneous fat during injection as this could increase the risk of intradermal exposure and potential skin ulceration and necrosis.</li><li>Avoid injecting into the post-platysmal fat by injecting BELKYRA into fat tissue at the depth of approximately mid-way into the subcutaneous fat layer (Figure 2).</li><li>If at any time resistance is met as the needle is inserted, indicating the possibility of contact with fascial or nonfat tissue, the needle must be withdrawn to an appropriate depth before the injection is administered.</li><li>Avoid injecting into other tissues such as the muscle, salivary glands and lymph nodes.</li><li>Upon needle withdrawal, pressure may be applied to each injection site as necessary to minimize bleeding; an adhesive dressing may be applied.</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                BELKYRA is contraindicated in the presence of infection at the injection sites.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>4.4.1. Marginal mandibular nerve injury</strong></p><p>Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness (paresis), were reported during clinical trials.&nbsp; To avoid the potential for nerve injury, BELKYRA should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.&nbsp; All marginal mandibular nerve injuries reported from the trials resolved spontaneously.</p><p><strong>4.4.2. Dysphagia</strong></p><p>Difficulty swallowing (dysphagia) occurred in clinical trials in the setting of administration site reactions, e.g., pain, swelling, and induration of the submental area.&nbsp; Cases of dysphagia spontaneously resolved.</p><p>Subjects with current or prior history of dysphagia were excluded from clinical trials.&nbsp; Avoid use of BELKYRA in these patients as current or prior history of dysphagia may exacerbate the condition.</p><p><strong>4.4.3. Injection site hematoma/bruising </strong></p><p>In clinical trials, 72% of subjects treated with BELKYRA experienced injection site hematoma/bruising <em>[see Undesirable Effects (4.8)]</em>.</p><p>BELKYRA should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.</p><p><strong>4.4.4. Risk of injecting in proximity to vulnerable anatomic structures</strong></p><p>To avoid potential tissue damage, BELKYRA should not be injected into or in close proximity (1-1.5 cm) to salivary glands, lymph nodes and muscles.</p><p><strong>4.4.5 Injection site alopecia in males</strong></p><p>Cases of injection site alopecia have been reported in males with the administration of BELKYRA. The</p><p>onset and duration of this adverse reaction may vary among individuals and may persist.</p><p>Consider withholding subsequent treatments until resolution of the adverse reaction.</p><p><strong>4.4.6 Injection site ulceration and necrosis</strong></p><p>Injections that are too superficial (into the dermis) may result in skin ulceration and necrosis [see</p><p>Injection Technique]. Cases of injection site ulceration and necrosis have been reported</p><p>with the administration of BELKYRA. Do not administer BELKYRA into the affected area</p><p>until complete resolution of the adverse reaction.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinical medicine interaction studies have been conducted with BELKYRA.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p>There are no adequate and well-controlled studies of BELKYRA in pregnant women to inform the drug-associated risk. The background risk of major birth defects and miscarriage for the indicated population is unknown. However, the background risk of major birth defects in the U.S. general population is 2-4% and of miscarriage is 15-20% of clinically recognized pregnancies. In animal reproduction studies, no fetal harm was observed with the subcutaneous administration of deoxycholic acid to rats during organogenesis at doses up to 5 times the maximum recommended human dose (MRHD) of 100 mg.</p><p><em>Data</em></p><p><u>Animal Data</u></p><p>Embryofetal development studies have been performed in rats and rabbits using subcutaneous doses of deoxycholic acid administered during the period of organogenesis.&nbsp; For the basis of comparing animal to human doses, the MRHD is 1.7 mg/kg (100 mg/60 kg).&nbsp; No evidence of fetal harm was observed in rats at up to the highest dose tested (50 mg/kg) which is 5-fold higher than the MRHD of BELKYRA based on a mg/m<sup>2</sup> comparison.&nbsp; However, missing intermediate lung lobe was noted in rabbits at all dose levels tested including the lowest dose (10 mg/kg) which is 2-fold higher than the MRHD of BELKYRA based on a mg/m<sup>2</sup> comparison.&nbsp; These effects may be related to maternal toxicity, which was also seen at all dose levels tested.&nbsp; &nbsp;</p><p>&nbsp;</p><p><strong>Lactation</strong></p><p>There is no information available on the presence of chemically synthesized deoxycholic acid in human milk, the effects of the drug on the breastfed infant or the effects of the drug on milk production.&nbsp; The developmental and health benefits of breastfeeding should be considered along with the mother&#39;s clinical need for BELKYRA and any potential adverse effects on the breastfed child from BELKYRA or from the underlying maternal condition.</p><p>&nbsp;</p><p><strong>Fertility</strong></p><p>No effects on fertility were observed in male and female rats administered deoxycholic acid at subcutaneous doses up to 50 mg/kg (5 times the MRHD based on a mg/m<sup>2</sup> comparison) once weekly prior to and during the mating period and through gestation day 7 in female rats.<strong> </strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Because clinical trials are conducted under widely varying conditions, the adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.</p><p>In two double-blind, placebo-controlled clinical trials 513 subjects were treated with BELKYRA and 506 subjects were treated with placebo.&nbsp; The population was 19-65 years old, 85% were women, 87% Caucasian, 8% African American.&nbsp; At baseline the population had a mean BMI of 29 kg/m<sup>2</sup>, moderate to severe submental convexity (graded as 2 or 3 on a 0 to 4 scale) and without excessive skin laxity.&nbsp; Subjects received up to 6 treatments at least 1 month apart and were followed for up to 6 months after the last received treatment.</p><p>The frequency of adverse reactions arising from clinical experience is given as follows:</p><p>Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000) and not known (cannot be estimated from available data) adverse reactions are presented according to System Organ Class in Table 1.</p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="1" cellpadding="1" style="width:574px"><tbody><tr><td style="width:226px"><strong>System Organ Class</strong></td><td style="width:171px"><strong>Adverse Reaction<sup>a</sup></strong></td><td style="width:176px"><strong>Frequency</strong></td></tr><tr><td rowspan="2" colspan="1" style="width:226px">Gastrointestinal disorders</td><td style="width:171px">Nausea</td><td style="width:176px">Common</td></tr><tr><td style="width:171px">Dysphagia</td><td style="width:176px">Common</td></tr><tr><td rowspan="16" colspan="1" style="width:226px">General disorders and administration site conditions</td><td style="width:171px">Oedema/swelling</td><td style="width:176px">Very common</td></tr><tr><td style="width:171px">Haematoma/bruising</td><td style="width:176px">Very common</td></tr><tr><td style="width:171px">Pain</td><td style="width:176px">Very common</td></tr><tr><td style="width:171px">Numbness</td><td style="width:176px">Very common</td></tr><tr><td style="width:171px">Erythema</td><td style="width:176px">Very common</td></tr><tr><td style="width:171px">Induration</td><td style="width:176px">Very common</td></tr><tr><td style="width:171px">Paraesthesia</td><td style="width:176px">Very common</td></tr><tr><td style="width:171px">Nodule</td><td style="width:176px">Very common</td></tr><tr><td style="width:171px">Pruritus</td><td style="width:176px">Very common</td></tr><tr><td style="width:171px">Skin tightness</td><td style="width:176px">common</td></tr><tr><td style="width:171px">Site warmth</td><td style="width:176px">common</td></tr><tr><td style="width:171px">Nerve injury<sup>b</sup></td><td style="width:176px">common</td></tr><tr><td style="width:171px">Injection site haemorrhage</td><td style="width:176px">common</td></tr><tr><td style="width:171px">Injection site discolouration</td><td style="width:176px">common</td></tr><tr><td style="width:171px">Lymphadenopathy</td><td style="width:176px">Uncommon</td></tr><tr><td style="width:171px">Injection site urticaria</td><td style="width:176px">Uncommon</td></tr><tr><td style="width:226px"><p>Musculoskeletal and connective tissue disorders</p></td><td style="width:171px"><p>Neck pain</p><p>&nbsp;</p></td><td style="width:176px">Uncommon</td></tr><tr><td rowspan="3" colspan="1" style="width:226px">Nervous system disorders</td><td style="width:171px">Headache</td><td style="width:176px">Common</td></tr><tr><td style="width:171px">Pre-syncope</td><td style="width:176px">Uncommon</td></tr><tr><td style="width:171px">Syncope</td><td style="width:176px">Uncommon</td></tr><tr><td style="width:226px">Respiratory, thoracic and mediastinal disorders</td><td style="width:171px">Oropharyngeal pain</td><td style="width:176px">Common</td></tr><tr><td style="width:226px">Vascular disorders</td><td style="width:171px">Hypertension</td><td style="width:176px">Common</td></tr></tbody></table><p><sup>a</sup>Adverse reactions that occurred in &ge; 2% BELKYRA treated subjects and at greater incidence than placebo</p><p><sup>b</sup>Marginal mandibular nerve paresis</p><p>&nbsp;</p><p>Adverse reactions that lasted more than 30 days and occurred in more than 10% of subjects were injection site numbness (42%), injection site oedema/swelling (20%), injection site pain (16%), and injection site induration (13%).</p><p>&nbsp;</p><p><strong>Postmarketing Experience:</strong></p><p>The following adverse reactions have been identified during post-approval use of BELKYRA.</p><p>Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to BELKYRA exposure.</p><p>Administration site/ injection site conditions: ulceration, necrosis, alopecia in males and anaesthesia/ hypoaesthesia.</p><p>&nbsp;</p><p>Reporting of suspected adverse reactions</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><p><strong>The national pharmacovigilance center and drug safety center</strong> (NPC):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: &nbsp;+966-11-205-7662</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at &nbsp;+966-11-20382222, Exts: 2353-2356-2317-2354-2334-2340</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone: 8002490000</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: <u>npc.drug@sfda.gov.sa</u></p><p>Website: <u>www.sfda.gov.sa/npc</u></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Injection of increased volume or decreasing the spacing of BELKYRA may increase the risk of adverse reactions.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC code: D11AX24</p><p>BELKYRA (deoxycholic acid) injection, 10 mg/mL is a clear colorless, sterile solution for subcutaneous use.&nbsp; It contains a cytolytic agent, deoxycholic acid, as the active ingredient.&nbsp; The chemical name of deoxycholic acid is 3&alpha;,12&alpha;-dihydroxy-5&beta;-cholan-24-oic acid, and its molecular formula is C<sub>24</sub>H<sub>40</sub>O<sub>4</sub>, and its molecular weight is 392.57 g/mol.&nbsp; The chemical structure of deoxycholic acid is:</p><p>&nbsp;</p><p><img src="data:image/png;base64,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" alt="" width="580" height="242" vspace="0" hspace="0" border="0" style="width:580px;height:242px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>Each 2 mL vial of BELKYRA (deoxycholic acid) injection contains 20 mg chemically synthesized (nonanimal-derived) deoxycholic acid as the active ingredient and the following inactive ingredients: benzyl alcohol (18 mg), dibasic sodium phosphate (2.84 mg), sodium chloride (8.76 mg), sodium hydroxide (2.86 mg) in water for injection, USP.&nbsp; Hydrochloric acid and additional sodium hydroxide are added as necessary to adjust the formulation to pH 8.3.&nbsp; Each vial is for single patient use.</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>BELKYRA is a cytolytic drug, which when injected into tissue physically destroys the cell membrane causing lysis.</p><p><u>Pharmacodynamics</u></p><p><em>Cardiac Electrophysiology</em></p><p>At therapeutic doses, BELKYRA does not prolong the QTc interval.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Endogenous deoxycholic acid plasma levels are highly variable within and between individuals; most of this natural bile component is sequestered in the enterohepatic circulation loop.&nbsp;</p><p><em>Absorption and Distribution</em></p><p>Deoxycholic acid from BELKYRA is rapidly absorbed following subcutaneous injection.&nbsp; After dosing with the maximum recommended single treatment dose with BELKYRA (100&nbsp;mg), maximum plasma concentrations (mean C<sub>max</sub>) were observed with a median T<sub>max</sub> of 18 minutes after injection.&nbsp; The mean (&plusmn;SD) C<sub>max</sub> value was 1024 &plusmn; 304 ng/mL and was 3.2-fold higher than average C<sub>max</sub> values observed during a 24-hour baseline endogenous period in the absence of BELKYRA.&nbsp; After maximum recommended single treatment dose (100 mg), mean (&plusmn;SD) deoxycholic acid exposure (AUC<sub>0-24</sub>) was 7896 &plusmn; 2269 ng.hr/mL and was 1.6-fold higher over endogenous exposure.&nbsp; Post-treatment deoxycholic acid plasma levels returned to the endogenous range within 24 hours.&nbsp; No accumulation is expected with the proposed treatment frequency.</p><p>Deoxycholic acid is extensively bound to proteins in plasma (98%).</p><p><em>Metabolism and Excretion</em></p><p>Endogenous deoxycholic acid is a product of cholesterol metabolism and is excreted intact in feces.&nbsp; Deoxycholic acid is not metabolized to any significant extent under normal conditions. Deoxycholic acid from BELKYRA joins the endogenous bile acid pool in the enterohepatic circulation and is excreted along with the endogenous deoxycholic acid.</p><p><em>In Vitro Assessment of Drug Interactions</em></p><p>Results from in vitro studies indicate that deoxycholic acid does not inhibit or induce human cytochrome P450 (CYP) enzymes at clinically relevant concentrations.&nbsp; Deoxycholic acid does not inhibit the following transporters: P-gp, BCRP, MRP4, MRP2, OATP1B1, OATP2B1, OATP1B3, OCT1, OCT2, OAT1, OAT3, NTCP, and ASBT.</p><p><em>Specific Populations</em></p><p><u>Hepatic Impairment</u></p><p>BELKYRA has not been studied in subjects with hepatic impairment.&nbsp; Considering the intermittent dose frequency, the small dose administered that represents approximately 3% of the total bile acid pool, and the highly variable endogenous deoxycholic acid levels, the pharmacokinetics of deoxycholic acid following BELKYRA injection is unlikely to be influenced by hepatic impairment.&nbsp;&nbsp;</p><p><u>Pharmacokinetic Effects of Gender </u></p><p>Deoxycholic acid pharmacokinetics were not influenced by gender.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Carcinogenesis, Mutagenesis</u></p><p>Long-term studies in animals have not been performed to evaluate the carcinogenic potential of BELKYRA.</p><p>BELKYRA<strong> </strong>was negative in a battery of in vitro (Ames test and chromosomal aberration assay in human lymphocytes) and in vivo (rat erythrocyte micronucleus assay) genetic toxicology assays.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preservative: Benzyl alcohol (0.9% m/v).</p><p>Excipients:</p><p>- Dibasic sodium phosphate</p><p>- Sodium chloride</p><p>- Sodium hydroxide&nbsp; in water for injection, USP&nbsp;</p><p>Hydrochloric acid and additional sodium hydroxide are added as necessary to adjust the pH.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                30 months.
If not used immediately, in-use storage times and conditions are the responsibility of the user. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vial (Type I glass), fitted with a stopper (chlorobutyl rubber) and a seal (aluminium) with flip-top lid (polypropylene).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Each vial is for single patient use only. After use, discard any unused product.</p><p>BELKYRA has a unique hologram on the vial label.&nbsp; If you do not see a hologram, do not use the product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Allergan Inc.
2525 Dupont Drive
Irvine
United States

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                January 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>